Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142980 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 |
| Mol.Wt. | 451.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142981 |
| CAS No | NA |
| Mol.F. | C15H20N2O4 |
| Mol.Wt. | 292.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142982 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 |
| Mol.Wt. | 451.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142983 |
| CAS No | NA |
| Mol.F. | C21H21FN4O5 |
| Mol.Wt. | 428.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142984 |
| CAS No | NA |
| Mol.F. | C15H21FN4O4 |
| Mol.Wt. | 340.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142985 |
| CAS No | NA |
| Mol.F. | C13H17ClFN3O3 |
| Mol.Wt. | 317.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142986 |
| CAS No | NA |
| Mol.F. | C18H18FN3O4 |
| Mol.Wt. | 359.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142987 |
| CAS No | NA |
| Mol.F. | C16H20N4O5 |
| Mol.Wt. | 348.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142988 |
| CAS No | NA |
| Mol.F. | C13H16FN3O3 |
| Mol.Wt. | 281.29 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142989 |
| CAS No | NA |
| Mol.F. | C12H14FN3O3 |
| Mol.Wt. | 267.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142990 |
| CAS No | NA |
| Mol.F. | C16H19FN4O6 |
| Mol.Wt. | 382.35g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142991 |
| CAS No | NA |
| Mol.F. | C15H21FN4O4 |
| Mol.Wt. | 340.36g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142992 |
| CAS No | NA |
| Mol.F. | C16H19FN4O4S |
| Mol.Wt. | 382.41g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142993 |
| CAS No | NA |
| Mol.F. | C14H17FN4O5 |
| Mol.Wt. | 340.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142994 |
| CAS No | NA |
| Mol.F. | C17H21FN4O5 |
| Mol.Wt. | 380.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142995 |
| CAS No | NA |
| Mol.F. | C172H264N44O52 |
| Mol.Wt. | 3780.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |